Monsanto, Roberto .

HRN: 24-13-58  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2023
CEFTRIAXONE 1G (VIAL)
11/26/2023
12/01/2023
IV
2g
Q24H
Multiple Soft Tissue Injury
Checking Final Appropriateness 
11/26/2023
MUPIROCIN 2%, 15G (TUBE)
11/26/2023
12/02/2023
TOPICAL
Thinly
BID
Multiple Soft Tissue Injury
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: